Abstract:Dear Editor, Determination of the percentage of blasts in the bone marrow (BM) is one of the critical factors in diagnosing MDS. Flow cytometry (FCM) of BM cells has been introduced as an important co-criterion for diagnosing MDS [1-3]. However, FCM has not been well accepted because of the lack of consensus of the criteria to define a phenotypic myeloblast and the appropriate denominator for calculation. Moreover, BM samples contain variable amounts of peripheral blood mixed with immature cells, thereby complicating interpretation. The present study was designed to choose reagent combinations to identify blasts by FCM in MDS patients, to determine which cell mass as the denominator in the process of counting the percentages of blasts, and to reveal whether the aspirates with high proportions of mature neutrophils should be normalized based on the proportion of dim CD16 maturing myeloid cells. Sixty-nine patients with primary MDS were enrolled; BM samples were obtained from 20 control subjects without any known hematological disease and with normal blood cell counts. This study was approved by our institutional review board, and written informed consent was obtained from all subjects. Cell morphology was analyzed by conventional light microscopy, and the same BM samples were analyzed by FCM within 6 hr. The panel included four-color combinations of markers: HLA-DR-fluorescein isothiocyanate (FITC)/CD117-phycoerythrin (PE)/CD34-allophycocyanin (APC)/CD45-peridinin-chlorophyll protein (PerCP), CD16FITC/CD13-PE/CD11bAPC/CD45-PerCP, anti-ckappa-FITC/antilambda-PE/CD138APC/CD45-PerCP, and IgG1-FITC/IgG1-PE/ IgG1-APC/IgG1-PerCP. For each criterion, the percentage of blasts was calculated by using both the total number of nucleated BM cells (A) and the number of non-erythroid nucleated cells (N) as the denominator. For the A1 and N1 methods, blasts were defined as events showing a CD34 and CD45 phenotype. The A2 and N2 strategies identified CD34 and/or CD117 cells showing CD45 expression as corresponding to blasts. For the A3 and N3 methods, blasts were defined as events showing a CD34 and/or CD117 HLA-DR and CD45 phenotype. The ratio of the percentage of dim CD16 neutrophils to the average percentage from BM biopsies (80%) was calculated as a dilution factor of excess mature segmented neutrophils in the sample. We used

A flow cytometric approach to compare stem cell apoptosis in aplastic anemia and hypoplastic myelodysplastic syndrome

The ratio of bone marrow myeloid progenitor cell proportion to mature lymphocytes proportion can effectively differentiate aplastic anemia and hypoplastic myelodysplastic syndrome and evaluate the quality of bone marrow aspirates

Comparison of T lymphocyte subsets in aplastic anemia and hypoplastic myelodysplastic syndromes

[The Value of Flow Cytometry for the Differential Diagnosis Between Refractory Cytopenia with Multiple Dysplasia and Aplastic Anemia].

[Analysis of Lymphocyte Subsets in Peripheral Blood of Patients with Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome]

Correlation Between Bone Marrow Blasts Counts with Flow Cytometry and Morphological Analysis in Myelodysplastic Syndromes

Value Of Flow Cytometry For Differential Diagnosis Between Refractory Cytopenia With Multilineage Dysplasia And Aplastic Anemia

Differential Gene Expression Profile Associated with the Abnormality of Bone Marrow Mesenchymal Stem Cells in Aplastic Anemia.

A study on T - cell subgroup in peripheral blood of children with aplastic anemia

Changes and Clinical Significances of CD4~+T Cell Subsets in Aplastic Anemia, Myelodysplastic Syndromes and Acute Myeloid Leukemia Patients

Performance of Automatic Blood Cell Analysis Parameters for Differential Diagnosis of Myelodysplastic Syndromes and Aplastic Anemia

Analysis of Mean Corpuscular Volume and Red Cell Distribution Width in Patients with Aplastic Anemia

Reduced Regulatory Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Activated T Lymphocytes and Th1/Th2 Cytokine Secretion in Children with Aplastic Anemia.

Significance of Morphological Examination, Cytochemical Staining Combined with Bone Marrow Biopsy in Differential Diagnosis of Myelodysplastic Syndrome with Low Blasts and Hemolytic Anemia

Changes and Clinical Significance of CD8+T Cell Subset in Patients with Aplastic Anemia, Myelodysplastic Syndrome and Acute Myeloid Leukemia

Qualitative flow cytometric analysis of Malaysian myelodysplastic syndromes (MDS) patients

Comparison Of Immunological Abnormalities Of Lymphocytes In Bone Marrow In Myelodysplastic Syndrome (Mds) And Aplastic Anemia (Aa)

Flow cytometric analysis of signaling and apoptosis in hematopoietic stem cells.

[Osteogenic and Adipogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Aplastic Anemia].

Flow Cytometric Analysis of CD64 Expression Pattern and Density in the Diagnosis of Acute Promyelocytic Leukemia: a Multi-Center Study in Shanghai, China

[Study on Apoptosis in Myelodysplastic Syndromes by DNA in Situ End Labelling Combined with APAAP].